What is TEVA's market cap?

$48.81B, based on the Nov 4 close of $41.85.

What is TEVA's P/E ratio?

69.0× trailing-twelve-month earnings of $707M.

Does Teva Pharmaceutical Industries Limited pay a dividend?

No regular cash dividend has been paid in the last year.

How much of TEVA is sold short?

28.1M shares, 2.4% of float, as of Oct 15, 2026.

What sector is TEVA in?

Healthcare, in the Pharmaceuticals industry.

NYSE · TEVAHealthcarePharmaceuticals

Teva Pharmaceutical Industries Limited (TEVA)

$41.85−0.14%

Close Nov 4, 2026 · split-adjusted

Nov 3, 2026$41.91▲ 104.24% in range

Nov 3, 2025Low $20.46 · High $42.09Nov 3, 2026

What changed · written from our data

As of Nov 4, 2026

Teva Pharmaceutical Industries Limited closed at $41.85 on Nov 4, down 0.14%, 0.6% below its 52-week closing high. Volume of 10.0M shares was 1.46× its 20-day average (above normal).

Split-adjusted performance: +7.0% over one month, +15.2% over six months, +103.9% over one year.

In the quarter ended Jun 30, 2026, revenue was $4.14B, down 0.8% from a year earlier, with a net margin of -13.9%.

Short interest was 28.1M shares at the Oct 15 settlement, down 6.0% from the prior report (2.4% of float, 3.9 days to cover).

Market cap$48.81B1.17B shares

Revenue · quarter$4.14B−0.8% YoY

Diluted EPS$-0.49−304.2% YoY

P/E · TTM69.0×P/S 2.8×

Net margin-13.9%Gross 52.0%

Dividend yieldNone$0.085 last paid

52-week range20.46 – 42.09−0.6% from high

Volume10.0M1.46× 20-day avg

Volatility · 60d28.5%Annualised

Short % of float2.4%3.9 days to cover

Net cash-$12.94BCash $3.65B

Next earnings—Not scheduled

Split-adjusted performance

1W +4.7%1M +7.0%3M +20.2%6M +15.2%YTD +34.1%1Y +103.9%3Y +389.5%5Y +368.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum80

Revenue growth41

Net margin62

Value (low P/E)16

Size98

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short28.1M−6.0% vs prior

Days to cover3.9Settled Oct 15

% of float2.4%

Short vol. 10d29.6%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
TEVATeva Pharmaceutical Industries Limited	$41.85	−0.14%	+15.2%	−0.8%	−13.9%	69.0	$48.81B
ZTSZOETIS	$89.20	+7.48%	−19.8%	−0.2%	28.0%	14.1	$36.86B	Compare
RPRXRoyalty Pharma	$67.56	+1.75%	+33.2%	+16.5%	2.7%	36.9	$30.08B	Compare
ROIVRoivant Sciences	$38.23	+6.08%	+32.7%	−33.5%	−13164.8%	—	$27.61B	Compare
UTHRUnited Therapeutics	$608.49	+1.19%	+2.0%	−1.9%	42.5%	19.9	$26.10B	Compare
REGNRegeneron Pharmaceuticals	$930.67	−4.39%	+29.1%	+36.3%	38.1%	20.0	$96.28B	Compare
INSMInsmed	$110.00	+5.32%	−19.8%	+268.4%	−19.1%	—	$24.13B	Compare
VTRSViatris	$19.22	+1.59%	+20.5%	+4.9%	−3.2%	—	$22.08B	Compare
ALNYAlnylam Pharmaceuticals	$161.08	+0.74%	−46.8%	+16.7%	148.6%	7.9	$21.57B	Compare

News about Teva Pharmaceutical Industries Limited

All news →

Teva Stock Has More Than Doubled in a Year. Where Will It Be in 3 Years?The Motley Fool · 5d ago▲ Positive Teva to Host R&D Day on Wednesday, November 11 in New York CityGlobeNewswire Inc. · Oct 12, 2026▲ Positive TEVA Gets FDA Nod for Weltruza as Once-Monthly LAI in SchizophreniaZacks Investment Research · Oct 12, 2026▲ Positive Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug TurnaroundThe Motley Fool · Sep 29, 2026▲ Positive Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ETGlobeNewswire Inc. · Sep 23, 2026Neutral

Quick answers

What does Teva Pharmaceutical Industries Limited do?: Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US.
What is TEVA's market cap?: $48.81B, based on the Nov 4 close of $41.85.
What is TEVA's P/E ratio?: 69.0× trailing-twelve-month earnings of $707M.
Does Teva Pharmaceutical Industries Limited pay a dividend?: No regular cash dividend has been paid in the last year.
How much of TEVA is sold short?: 28.1M shares, 2.4% of float, as of Oct 15, 2026.
What sector is TEVA in?: Healthcare, in the Pharmaceuticals industry.

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

HQ: Tel Aviv, 32,842 employeesListed Feb 16, 1982tevapharm.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology